MagicMed Industries

MagicMed Industries

Private Company
Public Company
Subsidiary of
Clinical Trials, R&D


MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. MagicMed's molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin, and is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, Ibogaine, Mescaline, and Ayahuasca.


MagicMed scientists start with a natural psychedelic molecule such as psilocybin and modify its structure to create many new derivative variant molecules which will form part of the MagicMed Psybrary™.

The proprietary scientific tools MagicMed employs for its derivatizations are trade secrets developed in-house from our decades of research and development in the field of natural product biochemistry.

Natural molecules such as psilocybin cannot be patented as a molecular composition. New molecular derivative compositions in the PsybraryTM are patentable as are MagicMed’s proprietary methods of manufacturing the derivatives within the Psybrary™.

MagicMed partners will be able to search, select and test from the derivatives in the Psybrary™ and use them as a building block for their own product development based on the indication that they are targeting (anxiety, depression, addiction, PTSD and many others).

The MagicMed team will then continue to work with its partners to further define and improve upon their selected derivative molecules to create finished medicinal product candidates and, in future, licit consumer products.

Once developed and approved, MagicMed's Industry partners will sell products into medical and licit consumer markets.

MagicMed’s partners potentially gain a significant edge over their competitors in new product development based on Psybrary™ molecules that are fully patent protected.

MagicMed will work with partners post-development to monitor the market progress of the products produced in partnership with us to help them to continuously improve and expand.

Virtual Roadshow